Cargando…
Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-κB-mediated inflammation
Increased inflammation and abnormal placentation are common features of a wide spectrum of pregnancy-related disorders such as intra uterine growth restriction, preeclampsia and preterm birth. The inflammatory response of the human placenta has been mostly investigated in relation to cytokine releas...
Autores principales: | Kadam, Leena, Kilburn, Brian, Baczyk, Dora, Kohan-Ghadr, Hamid Reza, Kingdom, John, Drewlo, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376060/ https://www.ncbi.nlm.nih.gov/pubmed/30765769 http://dx.doi.org/10.1038/s41598-018-38336-2 |
Ejemplares similares
-
The Role of NFκB in Healthy and Preeclamptic Placenta: Trophoblasts in the Spotlight
por: Armistead, Brooke, et al.
Publicado: (2020) -
Rosiglitazone-Mediated Activation of PPARγ Restores HO1 Expression in the Human Preeclamptic Placenta
por: Grimaldi, Brooke, et al.
Publicado: (2023) -
The Potential for Placental Activation of PPARγ to Improve the Angiogenic Profile in Preeclampsia
por: Grimaldi, Brooke, et al.
Publicado: (2022) -
Potential role of epigenetic mechanisms in regulation of trophoblast differentiation, migration, and invasion in the human placenta
por: Kohan-Ghadr, Hamid-Reza, et al.
Publicado: (2016) -
SUMO-4: A novel functional candidate in the human placental protein SUMOylation machinery
por: Baczyk, Dora, et al.
Publicado: (2017)